SCHEMBL22030723

SCHEMBL22030723

COc1ccc(-c2ccccc2C(=O)OCN)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 1/20 0.43
▸ CNR2 P34972 1/20 0.43
▸ MAPT P10636 3/20 0.42
▸ RAB9A P51151 2/20 0.42
▸ USP2 O75604 2/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ KDM4E B2RXH2 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ CASP3 P42574 1/20 0.42
▸ SENP8 Q96LD8 1/20 0.42
▸ SENP7 Q9BQF6 1/20 0.42
▸ SENP6 Q9GZR1 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.41
▸ POLB P06746 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ CDC7 O00311 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16107363 0.88 TSHR (0.51) CNR1CNR2MAPTRAB9AL3MBTL1
SCHEMBL16107035 0.81 SMN1; SMN2 (0.53) RAB9AUSP2KDM4EKMT2AMEN1
SCHEMBL8801038 0.76 CES2 (0.54) MAPTRAB9AKDM4ENPC1KMT2A
SCHEMBL1712444 0.73 TSHR (0.56) MAPTRAB9AUSP2L3MBTL1KDM4E
SCHEMBL12325069 0.72 HSP90AA1 (0.56) MAPTRAB9AKDM4ETSHRKMT2A
SCHEMBL31449995 0.71 SLC6A4 (0.50) MAPTRAB9AL3MBTL1KDM4ENPC1
SCHEMBL1712613 0.71 TSHR (0.53) MAPTUSP2KDM4ETSHRKMT2A
SCHEMBL16871335 0.71 SLC6A3 (0.65) CNR1MAPTTSHRKMT2AMEN1
SCHEMBL7611832 0.70 PPARG (0.52) MAPTRAB9AUSP2L3MBTL1KDM4E
SCHEMBL29114924 0.70 SCN1A (0.57) KMT2AMEN1LMNAADORA3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200163937-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-05-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200163937-A1 PYRAZOLE-AMIDE COMPOUNDS AND PHARMACEUTICAL USE THEREOF NAT1, CYP2C19, CYP3A5 CNR1 562/4885CNR2 571/4885MAPT 1075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback